Holen Sie sich die Stockscreener-App
511.00
0.99%
-5.12
Handel nachbörslich:
510.00
-1.00
-0.20%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$516.12
Offen:
$516.05
24-Stunden-Volumen:
2.38M
Relative Volume:
1.39
Marktkapitalisierung:
$183.15B
Einnahmen:
$8.71B
Nettoeinkommen (Verlust:
$2.48B
KGV:
74.93
EPS:
6.82
Netto-Cashflow:
$1.75B
1W Leistung:
-0.24%
1M Leistung:
+0.32%
6M Leistung:
-16.29%
1J Leistung:
+10.82%
1-Tages-Spanne:
$508.27
$519.83
1-Wochen-Bereich:
$506.21
$523.09
52-Wochen-Spanne:
$425.00
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Vergleichen Sie ISRG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-09 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Hochstufung | Erste Group | Hold → Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Intuitive Surgical Exceeds Expectations As Robot Surgeries Climb - Finimize
Intuitive Surgical reports upbeat quarterly earnings on strong demand for surgical robots - TradingView
Intuitive Surgical (ISRG) Reports Strong Q2 Results, Exceeds Exp - GuruFocus
Intuitive Surgical (ISRG) Faces Margin Pressure Despite Q2 Succe - GuruFocus
Intuitive (ISRG) Q2 2025 Earnings Transcript - The Globe and Mail
Earnings call transcript: Intuitive Surgical Q2 2025 earnings beat expectations - Investing.com
Intuitive Surgical (ISRG) Faces Macro Challenges Amid Strong Cap - GuruFocus
After-hours movers: Texas Instruments, Intuitive Surgical, Enphase Energy, and more - Investing.com Nigeria
Intuitive Surgical Inc. Announces Advance In Q2 Income - Nasdaq
Intuitive Surgical, Inc. (ISRG) Q2 Earnings and Revenues Top Estimates - Nasdaq
Intuitive Surgical down despite earnings beat on profit margin warning from tariffs - Seeking Alpha
Intuitive Surgical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Intuitive Surgical Inc. Bottom Line Climbs In Q2 - Nasdaq
Strong Q2 Performance for Intuitive Surgical (ISRG) with Revenue Surge | ISRG Stock News - GuruFocus
Intuitive Surgical (ISRG) Q2 2025 Earnings: EPS of $1.81 Beats Estimates, Revenue Surges to $2.44 Billion - GuruFocus
Intuitive Surgical Beats Q2 Earnings Estimates As Revenue Jumps 21%, Shares Slide - Benzinga
Intuitive Announces Second Quarter Earnings | ISRG Stock News - GuruFocus
Intuitive Surgical Slides Despite Second-Quarter Beat, Slight Guidance Boost - inkl
Robotic Surgery Titan Hikes Its Guidance. But Shares Topple. - Investor's Business Daily
Intuitive Surgical (NASDAQ:ISRG) Beats Expectations in Strong Q2 - TradingView
Robotic surgery giant Intuitive falls on profit margin concerns By Investing.com - Investing.com South Africa
Intuitive Surgical sees FY25 procedure growth 15.5%-17% - TipRanks
Intuitive Announces Second Quarter Earnings - GlobeNewswire
Intuitive Surgical (ISRG) Tops Q2 EPS by 26c - StreetInsider
Intuitive Surgical Q2 2025 Financial Results - TradingView
Intuitive Earnings Reveal Record-Breaking Quarter: Revenue Hits $2.44B as Robotic Surgery Demand Explodes - Stock Titan
Live: Intuitive Surgical (Nasdaq: ISRG) Earnings Preview Coverage - 24/7 Wall St.
Intuitive Surgical (ISRG) Sees Elevated Options Activity Ahead o - GuruFocus
Spine Surgery Robots Market Is Booming So Rapidly 2025-2032 - openPR.com
Intuitive Surgical: If You're Looking For A Dip To Buy, Get It Now (Rating Upgrade) - Seeking Alpha
ISRG vs. SYK: Which Robotic Surgery Stock Is the Stronger Buy Today? - The Globe and Mail
ISRG Stock Before Q2 Earnings Release: To Buy or Not to Buy? - The Globe and Mail
Intuitive Surgical Inc. Stock Analysis and ForecastTriple-digit growth rates - jammulinksnews.com
Orthopedic Surgical Robots Market is projected to grow to US$ - openPR.com
What drives Intuitive Surgical Inc. stock priceExponential wealth increase - Autocar Professional
St. Anthony Hospital debuts next gen robotic surgery system - The Journal Record
Experimental surgery performed by AI-driven surgical robot - Ars Technica
Da Vinci Robotic Surgical System Market Growing with Minimally - openPR.com
Robotic-Assisted Surgery Systems Market Booming with - openPR.com
Robotic Surgical System Device Market Thriving with AI Integration and Next-Generation Surgery Innovation, 2025-2032 - openPR.com
Intuitive Surgical Q2 Preview: Procedure Volume and Demand in Spotlight - Yahoo Finance
INTUITIVE SURGICAL INC (ISRG) Scores High on Benjamin Graham's Value Investor Model - AInvest
Robotic Flight Simulator Surgery Market Is Booming So Rapidly By 2032 | Intuitive Surgical, TransEnterix, Titan Medical - openPR.com
Intuitive Surgical (ISRG) Earnings Preview: What to ExpectNews and Statistics - IndexBox
Healthcare Robotics Localization Market Generated - openPR.com
Unlocking Q2 Potential of Intuitive Surgical (ISRG): Exploring Wall Street Estimates for Key Metrics - MSN
Intuitive Surgical (ISRG) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
FDA Approves Intuitive Surgical (ISRG) Vessel Sealer Curved Surgical Instrument - MSN
Is Intuitive Surgical Inc. a good long term investmentConsistent triple-digit returns - jammulinksnews.com
Prediction: 3 Magnificent Stocks That'll Be Worth More Than Nvidia and Palantir by 2035 - The Motley Fool
What analysts say about Intuitive Surgical Inc. stockHigh-yield investments - Autocar Professional
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):